RSS Search

News  Feeds  Tags  Search Shortcuts

FeedsFarm.com > Imclone Study Shows Head Cancer Benefit and U.S. BioDefense, Inc. Explores Strategic Response to Bird Flu

Source:

Financial News USA (OTC: FNWU)

Language:

English

Domain:

www.financialnewsusa.com

Search financialnewsusa.com:

Imclone Study Shows Head Cancer Benefit and U.S. BioDefense, Inc. Explores Strategic Response to Bird Flu

17th Nov 2005, 18:17 GMT

City of Industry, CA --(www.FinancialNewsUSA.com)-- 11/17/2005 - Biotechnology industry news provided by Financial News USA (OTC: FNWU) Biopharmaceutical company Imclone Systems Inc. (Nasdaq:IMCL) said Wednesday that its Erbitux cancer drug combined with radiation significantly held the spread of he

View full story at www.financialnewsusa.com

Imclone Study Shows Head Cancer Benefit and U.S. BioDefense, Inc. Explores Strategic Response to Bird Flu related news:

Latest news from Financial News USA (OTC: FNWU):